Clear market notes built around the JSE, the rand, and what matters locally.

2026-10-15 21:54 • The Motley Fool Positive Axe Cap view: Selective

The article compares two major cannabis companies navigating industry challenges. Canopy Growth focuses on premium Canadian cannabis and European medical sales but faces internal control weaknesses and significant losses. Tilray Brands has diversified into beverages and international markets, posting record Q1 revenue of $257M with improving margins. The author recommends Tilray as the better choice due to its larger scale, diversified revenue streams, and clearer path to profitability, though both stocks remain risky investments in a volatile industry.

Axe note: Tilray’s scale and diversification give it the edge over Canopy Growth, despite risks in both names.

2026-10-15 21:10 • The Motley Fool Positive Axe Cap view: Selective

The article compares two semiconductor companies: Arm, which licenses chip architecture used in billions of devices globally with strong profitability and low risk, and Credo Technology Group, which provides high-speed interconnects for AI data centers with explosive 205% revenue growth but higher customer concentration risk. The author recommends Credo for its superior growth trajectory despite Arm's defensible business model.

Axe note: Arm offers steady, dependable royalty income while Credo boasts explosive growth but with higher risk.

2026-10-15 21:05 • The Motley Fool Positive Axe Cap view: Selective

Boeing stock has declined 11.3% over the past month and 26.7% from its 52-week high, but the author sees buying opportunity. The company averted a labor strike with 17,000 engineers and recently secured major defense contracts including development of next-generation carrier-based fighter jets and the F-47 to replace the F-15. Despite commercial aircraft challenges, the defense segment and government contract wins present potential upside.

Axe note: Boeing’s recent stock drop masks gains from key defense contracts and averted labor strikes.